BBHC
CVAC

Brown Brothers Harriman & Co’s CureVac CVAC Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-355
Closed -$1.21K – 1428
2024
Q2 		$1.21K Hold
355
– – ﹤0.01% 1094
2024
Q1 		$1.08K Hold
355
– – ﹤0.01% 1110
2023
Q4 		$1.5K Hold
355
– – ﹤0.01% 1075
2023
Q3 		$2.42K Hold
355
– – ﹤0.01% 1086
2023
Q2 		$3.7K Buy
+355
New +$3.17K ﹤0.01% 1078

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Brothers Harriman & Co's CVAC Position: Q3 2024 in Review

Brown Brothers Harriman & Co sold out of CureVac (CVAC) in Q3 2024, closing a stake of 355 shares — an estimated $1.21K sold.

Brown Brothers Harriman & Co first reported a position in CVAC in Q2 2023 and held it in 5 quarters. The position peaked at $3.7K in Q2 2023. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

  • Brown Brothers Harriman & Co reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 355 CureVac shares in Q3 2024, an estimated $1.21K.
  • Brown Brothers Harriman & Co first reported a position in CureVac in Q2 2023 and held it in 5 quarters.
  • Brown Brothers Harriman & Co's CureVac position peaked at $3.7K in Q2 2023.
  • 81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2024, filed 13 Nov 2024.